Key takeaways
- NAD+ is a coenzyme found in every cell that plays a role in energy production.
- We found no published human trials of NAD+ nasal spray and no registered trial on ClinicalTrials.gov. The closest study was in mice and lab-grown cells.
- Human trials on oral NAD+ support mostly studied precursors such as NMN and NR. They raised blood NAD+ markers, but health outcomes were mixed.
- No published trial has studied compounded oral NAD+.
- Compounded NAD+ is not FDA approved. A licensed provider decides whether it is appropriate for you, and in which form.
Does NAD+ nasal spray work?
No published human trial shows that NAD+ nasal spray works. As of 10.12.26, PubMed, Consensus and ClinicalTrials.gov list no human trial of it. The only published intranasal NAD+ study used mice and lab-grown cells and measured smell, not energy or aging. Human NAD+ research mostly studied oral precursors such as NMN and NR.
The intranasal study is reference [1]. Oral precursors raised blood NAD+ levels, but effects on health outcomes were mixed and often not significant [5].
What is NAD+?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell. It plays a role in how cells produce energy, and enzymes use it for DNA repair and cell signaling. Researchers have reported that NAD+ levels decline with age in some tissues, which is why NAD+ has drawn interest in aging research.
Sources: [3][5].
What is the difference between NAD+ nasal spray and oral NAD+?
The difference is the route. NAD+ nasal spray is sprayed into the nose, where it meets the nasal lining. Oral NAD+ is swallowed as a tablet or capsule and passes through the digestive tract and liver before reaching the bloodstream. Neither compounded form has been studied in published human trials.
| Form | Studied in published human trials | FDA approved |
|---|---|---|
| Compounded NAD+ nasal spray | No published human trials found | No |
| Compounded oral NAD+ | No. One trial tested a different, proprietary oral NAD+ formulation [6] | No |
| Oral NAD+ precursors (NR, NMN) | Yes, trials measured blood NAD+ [2][5] | No (sold as supplements) |
What does the research show for NAD+ nasal spray?
There are no published human trials of NAD+ nasal spray. A ClinicalTrials.gov search on 10.12.26 found no registered trial. The closest study gave NAD+ into the nose of mice with induced loss of smell and treated human smell-related stem cells in a dish. It did not study energy, aging or wellness in people.
The Stackhaus Health editorial team also searched PubMed and Consensus. The mouse and olfactory stem cell study is reference [1]. It measured smell-related outcomes in animals and does not show what NAD+ nasal spray does in people.
What does the research show for oral NAD+?
Most human research on oral NAD+ support studied precursors, compounds the body converts into NAD+, not NAD+ itself. A 2026 review of 33 human studies found that oral NR and NMN consistently raised NAD+-related markers and were generally well tolerated. Effects on function, metabolism and other health outcomes were mixed and often not significant.
That review is reference [5]. In a 12-week randomized, placebo-controlled trial in 30 healthy adults, 250 mg a day of the precursor nicotinamide mononucleotide (NMN) raised NAD+ levels in whole blood, with no obvious adverse effects [2].
One 2026 randomized trial tested a proprietary oral NAD+ formulation in 50 healthy adults for 5 days. It raised NAD+ inside blood cells but did not change NAD+ in plasma, and no clinical or wellbeing outcome changed after statistical correction [6]. That product was specially processed. Its results do not apply to compounded oral NAD+.
Raising a blood level is not the same as a health benefit. Higher measured NAD+ does not by itself show that a person will feel or function differently [5].
Is NAD+ FDA approved?
No. There is no FDA approved NAD+ drug in any form. Compounded NAD+ is prepared by a state-licensed pharmacy for an individual patient, and compounded medications are not FDA approved. The FDA does not review compounded drugs for safety, effectiveness or quality, and compounded NAD+ is not approved to treat any condition.
Source: [4]. FDA recall records reviewed on 10.12.26 for compounded NAD+ involve injectable vials and syringes, mostly over sterility concerns [7]. Stackhaus Health does not currently offer injectable NAD+.
Is NAD+ nasal spray safe?
Long-term safety of NAD+ nasal spray has not been studied. Reported side effects include nasal irritation, headache and nausea. Because compounded NAD+ is not FDA approved, complete information on how often side effects occur with each form is limited. A licensed provider reviews your health history and medications before deciding whether it is appropriate.
Important safety information. NAD+ may not be appropriate if you are pregnant or breastfeeding, or if you have a known sensitivity to nicotinamide or related compounds. Tell your provider about all medications, supplements and health conditions. Your provider reviews your health history before prescribing.
Which form is right for you?
A licensed provider decides. Neither NAD+ nasal spray nor oral NAD+ has been shown to work better than the other. Some patients prefer a spray and others prefer a tablet, but that is a preference, not evidence of better results. Your provider confirms which forms are available when reviewing your intake.
Which forms are available can change.
How does it work at Stackhaus Health?
You complete a free online intake about your health history and goals. A licensed provider reviews it and decides whether compounded NAD+ is appropriate. Completing the intake does not guarantee a prescription. If it is prescribed, a state-licensed pharmacy prepares and ships it, and the pharmacy name appears on your prescription label.
See compounded NAD+, all longevity options, our pharmacy network, does oral sermorelin work and our editorial policy.
What research supports
- Oral precursors NMN and NR raise blood NAD+ markers in people and were generally well tolerated in studies lasting weeks to months [2][5].
- One proprietary oral NAD+ formulation raised NAD+ inside blood cells over 5 days [6]. This does not apply to compounded products.
What research does not show
- Any published or registered human trial of NAD+ nasal spray.
- Any published human trial of compounded oral NAD+.
- A direct comparison of nasal and oral forms.
- Consistent health benefits from raising NAD+ in people [5].
- Long-term safety of any NAD+ form.
Frequently asked questions
Does NAD+ nasal spray work?
There is no published human trial showing that it does, and we found no registered trial on ClinicalTrials.gov. The closest research was in mice and lab-grown cells.
Is NAD+ nasal spray better than oral NAD+?
This has not been studied. We found no published trials comparing the two forms in people.
Is NAD+ nasal spray safe?
Long-term safety has not been studied in published trials. Reported side effects include nasal irritation, headache and nausea. Your provider reviews your health history before prescribing.
Do you need a prescription for NAD+ nasal spray?
For a compounded NAD+ nasal spray, yes. A licensed provider reviews your health history first, and a state-licensed pharmacy prepares it for you.
How often do you use NAD+ nasal spray?
Your provider sets how and how often you use it. Follow your prescription label.
Is oral NAD+ the same as NMN or NR?
No. NMN and NR are precursors the body converts into NAD+. Most human trials studied these precursors, not NAD+ itself.
Is compounded NAD+ FDA approved?
No. Compounded medications are not FDA approved. FDA does not review them for safety, effectiveness or quality.
Does Stackhaus Health offer NAD+ injections?
Not currently. Stackhaus Health's NAD+ is compounded as a nasal spray or tablet. Your provider confirms which forms are available.
Who should not take NAD+?
NAD+ may not be appropriate if you are pregnant or breastfeeding, or if you have a known sensitivity to nicotinamide or related compounds. Your provider reviews your health history.
References
- Yoo SH, Jang JY, Bae JS, et al. Therapeutic effect of intranasal nicotinamide adenine dinucleotide in the restoration of olfactory dysfunction. Exp Mol Med. 2026;58(7):2155-2167. PMID: 42380286. DOI
- Okabe K, Yaku K, Uchida Y, et al. Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects. Front Nutr. 2022;9:868640. PMID: 35479740. DOI
- Yaku K, Nakagawa T. NAD+ Precursors in Human Health and Disease: Current Status and Future Prospects. Antioxid Redox Signal. 2023;39(16-18):1133-1149. PMID: 37335049. DOI
- U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. FDA
- Gallagher C, Emmanuel OO. NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Res Rev. 2026;116:103057. PMID: 41655607. DOI
- Kornilov SA, Hastings WJ, McGrath LF, et al. Oral LNAD+ rapidly elevates whole blood intracellular NAD and metabolic flux without elevating plasma NAD: evidence from a randomized controlled trial. GeroScience. 2026. PMID: 42530810. DOI
- U.S. Food and Drug Administration. Drug enforcement reports (recalls), openFDA. Accessed 10.12.26. openFDA










